ProCE Banner Activity

Six Months Later: How COVID-19 Has Changed My Management of CLL

Clinical Thought
With the first 6 months of the COVID-19 pandemic behind us, I share how my management of patients with CLL has evolved based on experience and key data emerging on COVID-19 risk in patients with CLL.

Released: September 30, 2020

Expiration: September 29, 2021

No longer available for credit.

Share

Faculty

Jacob D. Soumerai

Jacob D. Soumerai, MD

Instructor
Attending Physician

Department of Medicine
Harvard Medical School
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca

Faculty Disclosure

Primary Author

Jacob D. Soumerai, MD

Instructor
Attending Physician

Department of Medicine
Harvard Medical School
Boston, Massachusetts

Jacob D. Soumerai, MD, has disclosed that he has received funds for research support from BeiGene, BostonGene, Genentech/Roche, GlaxoSmithKline, and TG Therapeutics and consulting fees from AbbVie, AstraZeneca, and Verastem.